Study of MAR002 in Healthy Men

Recruiting now · Phase 1 · Has a placebo group

Conditions studied: Acromegaly

In brief

Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men

Key facts

Study ID

NCT07195175

Run by

Marea Therapeutics

People needed

45

Starts

2025-08-11

Expected to finish

2026-07-01

Last updated by the study team

2026-01-12

Who can join

Age: 18 and older, up to 40. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Willingness to provide written informed consent
• Age 18 to 40
• Weight 55 to 95 kg
• Body mass index (BMI) 18 to 30 kg/m2
• Healthy men

You may not qualify if…

• History of hypersensitivity to monoclonal antibodies or study drug
• Participation in any other investigational drug study
• History of cancer
• Recent acute illness
• Positive test for HIV, hepatitis B/C
• History of substance abuse or nicotine use
• Recent blood donation
• History of pituitary disorder
• Any condition that prevents the participant from complying with study procedures

Where it is running

• Marea Site — Tempe, Arizona, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.